X4 Pharmaceuticals (XFOR) Net Cash Flow (QoQ) (2017 - 2025)
X4 Pharmaceuticals (XFOR) Net Cash Flow (QoQ) (2017 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,192.35 Bn | 67,192.06 Bn | - |
| 2 | Nanobiotix | 1,912.79 Bn | 1,912.72 Bn | - |
| 3 | Akari Therapeutics | 989.71 Bn | 989.71 Bn | - |
| 4 | BeOne Medicines | 471.52 Bn | 466.73 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.73 Bn | 114.48 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.88 Bn | 61.13 Bn | 3.31 Bn |
| 7 | Belite Bio | 63.11 Bn | 63.11 Bn | - |
| 8 | Argenx Se | 55.88 Bn | 50.70 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.48 Bn | 37.48 Bn | - |
| 10 | X4 Pharmaceuticals | 167.50 Mn | -49.55 Mn | 2.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 384.37% |
| Sep 30, 2025 | 2,659.80% |
| Jun 30, 2025 | 92.33% |
| Mar 31, 2025 | 62.62% |
| Dec 31, 2024 | 16.97% |
| Sep 30, 2024 | -194.05% |
| Jun 30, 2024 | 236.49% |
| Mar 31, 2024 | -19.81% |
| Dec 31, 2023 | 38.42% |
| Sep 30, 2023 | -418.67% |
| Jun 30, 2023 | 157.79% |
| Mar 31, 2023 | -169.00% |
| Dec 31, 2022 | 27.11% |
| Sep 30, 2022 | 273.19% |
| Jun 30, 2022 | -23.30% |
| Mar 31, 2022 | -377.89% |
| Dec 31, 2021 | 129.48% |
| Sep 30, 2021 | 7.59% |
| Jun 30, 2021 | -155.97% |
| Mar 31, 2021 | 454.73% |